Skip Navigation LinksHome > July 2013 - Volume 8 - Issue 4 > Progress in HIV-1 vaccine development
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e328361d178
THIRTY YEARS OF HIV AND AIDS: Edited by David A. Cooper and Giuseppe Pantaleo

Progress in HIV-1 vaccine development

Haynes, Barton F.a; McElrath, M. Julianab

Collapse Box


Purpose of review: In this review, examples of recent progress in HIV-1 vaccine research are discussed.

Recent findings: New insights from the immune correlates analyses of the RV144 efficacy trial have accelerated vaccine development with leads to follow in nonhuman primate studies and improved vaccine designs. Several new vaccine vector approaches offer promise in the exquisite control of acute infection and in improving the breadth of T-cell responses. New targets of broadly neutralizing antibodies (BnAbs) have been elucidated, and improved understanding of how the human host controls BnAb development have emerged from BnAb knock-in mice and from analyses of BnAb maturation and virus evolution in individuals followed from the time of HIV-1 transmission to BnAb induction.

Summary: Based on these observations, it is clear that the development of a successful HIV-1 vaccine will require new vaccine approaches and iterative testing of immunogens in well designed animal and human trials.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.